|
Session
|
Focus on the Drug Payment Methods Landscape
|
 |
|
Date/Time
|
April 17, 2009 @ 10:45 AM - 11:45 AM
|
|
|
Description
|
Change is the 2009 buzzword of the year. We have witnessed its touch on many of the areas we encounter on a daily basis. In the pharmacy arena, the dynamic subject of drug payment reform is the hot topic. The impact of court decisions and potential regulation in this highly volatile domain is a prime question on the minds of those engaged in nearly every aspect of pharmacy contracting. This session addresses what the likely impacts may be for the troublesome questions of what the new drug payment environment may dictate and when resolution is most likely to manifest itself. Faculty will share data currently being updated in the AMCP Guide to Pharmaceutical Payment Methods and its companion online drug payment reference library. Also a noted expert in the field will share his insights on what the future holds.
|
|
|
Learning Objectives
|
By attending this session, you should be able to:
- Identify recent changes that will affect drug payment methodologies in the US
- Calculate the anticipated impact of recent decisions on various stakeholders
- Cite elements that have changed with regard to pharmaceutical payment methods in the past year
|
|
|
Moderator
|
Jeff Hawes
Senior Director of Managed Care
P4 Healthcare, LLC
Granger, IN
|
|
|
Faculty
|
|
John Aforismo
|
CEO & Founder
|
R.J. Health Systems International, LLC
|
Thomas Bizzaro
|
Vice President, Health Policy and Industry Relations
|
First DataBank
|
Howard M. Tag
|
President
|
Tag & Associates, Inc.
|
|
|
